Masimo Corporation has announced the findings of a new clinical trial, published in JAMA Pediatrics, demonstrating the advantages of its SedLine® Brain Function Monitoring technology in pediatric anesthesia. The study, conducted by Dr. Yasuko Nagasaka and colleagues at Tokyo Women's Medical University, involved children aged 1 to 6 years undergoing elective surgery. The results showed that EEG-guided anesthesia using SedLine significantly reduced the exposure to sevoflurane, a commonly used inhalation anesthetic, and lowered the incidence of pediatric anesthesia emergence delirium (PAED). Children monitored with SedLine regained consciousness 53% sooner and were discharged from the post-anesthesia care unit 48% sooner compared to those in the control group. These outcomes suggest improvements in safety, efficiency, and cost-effectiveness of pediatric anesthesia. The findings have been presented and are available for review.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.